Endocrine Reviews, Vol 2, 306-326, Copyright © 1981 by Endocrine Society

ARTICLES

Lipoprotein utilization and cholesterol synthesis by the human fetal adrenal gland

BR Carr and ER Simpson

A model proposed for regulation of steroidogenesis, lipoprotein utilization and cholesterol metabolism in HFA tissue is presented in Fig 17. We envision that the role of ACTH and cAMP in steroidogenesis and cholesterol metabolism is as follows. ACTH binds to specific receptors on the surface of the cells of the HFA gland and as a consequence, adenylate cyclase is activated, leading to increased formation of cAMP. cAMP causes activation of protein kinase that leads, presumably, to phosphorylation of specific proteins. This leads to the initiation of reactions that give rise to increased activity of key enzymes and levels of proteins involved in adrenal cholesterol metabolism. Presumably, the action of ACTH causes an increase in the activity of cholesterol side chain cleavage, the rate-limiting step in the conversion of cholesterol to steroid hormones. We suggest that once the mitochondrial cholesterol side-chain cleavage system is fully activated by ACTH, the supply of cholesterol to the mitochondria becomes rate-limiting for steroidogenesis. To meet this demand for cholesterol, a further action of ACTH results in an increase in the number of LDL receptors. LDL binds to specific receptors on the cell surface that are localized in coated pits. LDL is internalized by a process of adsorptive endocytosis and the internalized vesicles fuse with lysosomes and the protein component of LDL is hydrolyzed by lysosomal proteolytic enzymes to amino acids. The cholesteryl esters of LDL also are hydrolyzed to give rise to fatty acids and cholesterol. The liberated cholesterol is available for utilization in the biosynthesis of steroid hormones and other cellular processes. In addition, ACTH stimulates the activity of HMG CoA reductase and, thus, the rate of de novo cholesterol biosynthesis. In this way sufficient cholesterol is obtained to provide for precursor cholesterol to maintain the high rate of steroid synthesis by the HFA. HDL is not utilized as a source of cholesterol by the HFA. Because of the rapid rate of utilization of LDL by the HFA, fetal plasma levels of LDL are low and the activity of the HFA is a primary determinant of these levels. Thus, in the case of anencephaly, in which the activity of the adrenal is very low, plasma levels of LDL are 2--3 times higher than in normal fetuses, whereas plasma HDL levels are similar. In addition, in the normal neonate plasma LDL levels rise rapidly after birth, and this event is coincident with the involution of the fetal zone of the adrenal. The fetal liver is likely to be the major source ultimately of the LDL-cholesterol utilized by the HFA. Consequently, factors that regulate cholesterol and lipoprotein synthesis in the fetal liver may, in turn, affect the steroidogenic activity of the HFA through regulation of the supply of cholesterol precursor. Thus, if trophic factors for the HFA other than ACTH exist, an important site of their action might be the fetal liver, rather than a direct action to influence the rate of synthesis of steroids by the fetal adrenal.

This article has been cited by other articles:

				F. B. Kraemer, W.-J. Shen, S. Patel, J.-i. Osuga, S. Ishibashi, and S. Azhar The LDL receptor is not necessary for acute adrenal steroidogenesis in mouse adrenocortical cells Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E408 - E412. [Abstract] [Full Text] [PDF]

				R. Sirianni, B. A. Mayhew, B. R. Carr, C. R. Parker Jr., and W. E. Rainey Corticotropin-Releasing Hormone (CRH) and Urocortin Act through Type 1 CRH Receptors to Stimulate Dehydroepiandrosterone Sulfate Production in Human Fetal Adrenal Cells J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5393 - 5400. [Abstract] [Full Text] [PDF]

				J. Seely, K. S. Amigh, T. Suzuki, B. Mayhew, H. Sasano, V. Giguere, J. Laganiere, B. R. Carr, and W. E. Rainey Transcriptional Regulation of Dehydroepiandrosterone Sulfotransferase (SULT2A1) by Estrogen-Related Receptor {alpha} Endocrinology, August 1, 2005; 146(8): 3605 - 3613. [Abstract] [Full Text] [PDF]

				K. J. Saner, T. Suzuki, H. Sasano, J. Pizzey, C. Ho, J. F. Strauss III, B. R. Carr, and W. E. Rainey Steroid Sulfotransferase 2A1 Gene Transcription Is Regulated by Steroidogenic Factor 1 and GATA-6 in the Human Adrenal Mol. Endocrinol., January 1, 2005; 19(1): 184 - 197. [Abstract] [Full Text] [PDF]

				K. S. Rehman, B. R. Carr, and W. E. Rainey Profiling the Steroidogenic Pathway in Human Fetal and Adult Adrenals Reproductive Sciences, September 1, 2003; 10(6): 372 - 380. [Abstract] [PDF]

				T. Ishii, T. Hasegawa, C.-I Pai, N. Yvgi-Ohana, R. Timberg, L. Zhao, G. Majdic, B.-c. Chung, J. Orly, and K. L. Parker The Roles of Circulating High-Density Lipoproteins and Trophic Hormones in the Phenotype of Knockout Mice Lacking the Steroidogenic Acute Regulatory Protein Mol. Endocrinol., October 1, 2002; 16(10): 2297 - 2309. [Abstract] [Full Text] [PDF]

				H. Li, M. Brochu, S. P. Wang, L. Rochdi, M. Cote, G. Mitchell, and N. Gallo-Payet Hormone-Sensitive Lipase Deficiency in Mice Causes Lipid Storage in the Adrenal Cortex and Impaired Corticosterone Response to Corticotropin Stimulation Endocrinology, September 1, 2002; 143(9): 3333 - 3340. [Abstract] [Full Text] [PDF]

				W. A. Freije, V. Pezzi, A. Arici, B. R. Carr, and W. E. Rainey Expression of 11{beta}-Hydroxylase (CYP11B1) and Aldosterone Synthase (CYP11B2) in the Human Fetal Adrenal Reproductive Sciences, November 1, 1997; 4(6): 305 - 309. [Abstract] [PDF]

				J. Liu, R. Voutilainen, P. Heikkila, and A. I. Kahri Ribonucleic Acid Expression of the CLA-1 Gene, a Human Homolog to Mouse High Density Lipoprotein Receptor SR-BI, in Human Adrenal Tumors and Cultured Adrenal Cells J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2522 - 2527. [Abstract] [Full Text] [PDF]

				J. L. Isaacsohn, R. G. Bakker-Arkema, R. Fayyad, R. Whitcomb, and D. M. Black Atorvastatin, a New HMG-CoA Reductase Inhibitor, Does Not Affect Glucocorticoid Hormones in Patients with Hypercholesterolemia Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 243 - 249. [Abstract] [PDF]

				B. Staels, G. Martin, M. Martinez, C. Albert, J. Peinado-Onsurbe, R. Saladin, D. W. Hum, M. Reina, S. Vilaro, and J. Auwerx Expression and Regulation of the Lipoprotein Lipase Gene in Human Adrenal Cortex J. Biol. Chem., July 19, 1996; 271(29): 17425 - 17432. [Abstract] [Full Text] [PDF]

				W. H. Kutteh, W. E. Rainey, and B. R. Carr Regulatory Effects of Multifunctional Cytokines and Steroid Hormones on Apolipoprotein B Production by Human Fetal Hepatocytes Reproductive Sciences, October 1, 1994; 1(4): 256 - 263. [Abstract] [PDF]